Recombinant Production of The Cyclotide Kalata B1 by Conditional Split Inteins
ChemBioChem · 2025
DOI: 10.1002/cbic.202400591 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemBioChem, 2025. Verfasst von Abdulkadir Yayci und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Molecular Bioscience, Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science, The University o…. Hauptthemen laut MEDLINE: Inteins, Cyclotides, Recombinant Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Australian Research Council (ARC), Centre of Excellence for Innovations in Peptide and Protein Science, German Research Foundation.
Abstract (Originalsprache)
This study describes the design, production, and characterization of a novel conditional intein system for the recombinant production of cyclic peptides. The system is based on two key features: (1) a promiscuous extein recognition site allowing cyclization of virtually any peptide, and (2) a secondary split site within the intein itself enabling triggered splicing at will. Two intein precursors were recombinantly expressed, purified, and then self‐assembled in vitro to cyclize the model peptide kalata B1 (kB1). Cyclized kB1 was successfully purified, refolded, and characterized by mass spectrometry and NMR, demonstrating correct disulfide bond formation and identical structure to synthetic kB1. Importantly, the intein‐derived kB1 retained full biological activity as evidenced by insect cell toxicity assays. This work establishes a versatile and efficient approach for intein‐mediated protein cyclization with potential applications in bioengineering and peptide discovery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Molecular Bioscience, Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science, The University of Queensland, Brisbane QLD, 4072, Australia.
ORCID-Profile: Abdulkadir Yayci, Yen-Hua Huang, Peta J Harvey, David J Craik
Förderung
- Australian Research Council (ARC)
- Centre of Excellence for Innovations in Peptide and Protein Science
- German Research Foundation
- National Health and Medical Research Council
- NHMRC
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Yayci, A., Huang, Y. H., Harvey, P. J., & Craik, D. J. (2025). Recombinant Production of The Cyclotide Kalata B1 by Conditional Split Inteins. ChemBioChem. https://doi.org/10.1002/cbic.202400591
Vancouver
Yayci A, Huang YH, Harvey PJ, Craik DJ. Recombinant Production of The Cyclotide Kalata B1 by Conditional Split Inteins. ChemBioChem. 2025. doi:10.1002/cbic.202400591
BibTeX
@article{Yayci2025,
author = {Yayci, Abdulkadir and Huang, Yen-Hua and Harvey, Peta J and Craik, David J},
title = {Recombinant Production of The Cyclotide Kalata B1 by Conditional Split Inteins},
journal = {ChemBioChem},
year = {2025},
doi = {10.1002/cbic.202400591}
}
EUVIMED